Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Stiripentol in Healthy Male Volunteers
NCT03866928Phase 1Completed
- Sponsor
- Biocodex
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of stiripentol in Dravet syndrome, sponsored by Biocodex. Primary endpoints: Maximum Plasma Concentration at Day 15, Area Under the Curve at Day 15 and 4 more. Started Feb 2019; status: completed.
02
Drugs
stiripentol
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT03866928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03866928.